Ratings Moves: MGM,...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$97.53 -0.20 | -0.20%
05/23/13 - 02:35 PM ET
3.50M / 1.81M
Vol / Avg. Vol:96.93 / 97.73
Open / Prev. Close:96.76 - 98.62
Today's Range:81.28 - 116.45
52 Wk Range:7.42%
Performance YTD:TheStreet Rating:
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGN 05.20.13 | 10:05 am
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.20.13 | 09:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Laggard 05.08.13 | 05:05 pm
- Mad Money Uncovered: Allergan
05.08.13 | 06:05 am - 'Mad Money' Lightning Round: Discover Financial Is Cheap -- Buy It 05.07.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Timing Is Everything 05.06.13 | 08:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
- Cramer's Top Stock Picks: AGN BP CRL PRU AIG 05.03.13 | 06:05 am
- Cramer's 'Mad Money' Recap: A New Dawn for Europe? 05.02.13 | 08:05 pm
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Apache, Windstream and Other Stocks Insiders Are Buying - Benzinga 04.06.13 | 12:04 pm
- Johnson & Johnson's Quest to Knock Botox off the Pedestal - Benzinga 03.22.13 | 02:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for February 26, 2013 - NASDAQ 02.22.13 | 02:02 pm
- Why I Sold Allergan - Seeking Alpha 02.01.13 | 07:02 pm
- How To Play The Cosmeceutical Market - Seeking Alpha 12.25.12 | 09:12 am
- Buy MAP Pharmaceutical For 70% Upside - Seeking Alpha 11.26.12 | 09:11 am
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for November 19, 2012 - NASDAQ 11.15.12 | 02:11 pm
